Immunoreactivity to Cetuximab in Cancer Patients

CompletedOBSERVATIONAL
Enrollment

538

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions
Colorectal CancerHead and Neck Cancer
Interventions
OTHER

immunologic technique

Sera from head and neck cancer or colorectal cancer patients who were treated with cetuximab will be obtained from Tumor Tissue Repository

OTHER

laboratory biomarker analysis

Sera from head and neck cancer or colorectal cancer patients who were treated with cetuximab will be obtained from Tumor Tissue Repository

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Vanderbilt-Ingram Cancer Center

OTHER

NCT00896896 - Immunoreactivity to Cetuximab in Cancer Patients | Biotech Hunter | Biotech Hunter